BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioLegend Releases Brilliant Violet 421(TM) Antibody Conjugates for Advanced Flow Cytometry Applications


4/14/2011 1:50:41 PM

SAN DIEGO, CA--(Marketwire - April 13, 2011) -

BioLegend, Inc., a provider of antibodies and reagents for biomedical research, announced today the release of over fifty Brilliant Violet 421™ antibody conjugates for use in flow cytometry and microscopy. BioLegend developed these reagents using Brilliant Violet 421™, the first in a series of novel polymer-based fluorophores developed by Sirigen from Nobel Prize-winning chemistry. It is excited by the 405 nm violet laser, and detected with the 450/50 nm filter typically used for Pacific Blue™ and BD Horizon™ V450. Brilliant Violet 421™ antibodies provide exceptional brightness, stability, reliability, and improved signal-to-noise over Pacific Blue™ by 10-fold or more.

"Brilliant Violet 421™ will enable researchers to more clearly resolve populations in multi-color flow cytometry analysis," said Gene Lay, CEO of BioLegend. "The brightness of BV421™ is on par with that of PE, providing an excellent dynamic range and making it a new first choice for researchers using the violet laser."

Brilliant Violet 421™ antibodies are fully compatible with currently used buffers and fixatives, and common cell staining techniques, suitable for both surface and intracellular staining of antigens. Its narrow excitation and emission spectra result in less requirement for cross-beam compensation and compensation into neighboring detectors. BioLegend plans to continue to expand this product line, providing more antibody specificities for mouse, rat and human research. For more information, visit www.biolegend.com/brilliantviolet.

About BioLegend:

BioLegend develops and manufactures world-class, cutting-edge antibodies and reagents at an outstanding value to customers for biomedical research. The broad product portfolio includes flow cytometry, cell biology, and functional reagents for research in immunology, cancer research, stem cells, and more. The aggressive product development program is accomplished through technology licensing, collaborations, and internal research. BioLegend offers a wide range of custom services including assay development, sample testing, and conjugation. BioLegend was incorporated in June, 2002 with headquarters in San Diego, CA.


CONTACT:
Dzung Nguyen
Associate Director, Technical Marketing
BioLegend, Inc.
(858)768-5880
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

BioLegend
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES